Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage
- 5 January 2010
- journal article
- research article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 22 (6) , 618-e173
Abstract
Acotiamide is a selective acetylcholinesterase inhibitor and enhances the actions of cholinergic neurons localized in the stomach. The present two studies were conducted to examine the optimal dosage of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia (FD) in Japan. The improvement rate of 'subjects global assessment of overall treatment efficacy (OTE)' at the final evaluation was approximately 10% higher in the acotiamide 100 mg group than that in the placebo group with good reproducibility though there was no significant differences at primary endpoint. The elimination rate of postprandial fullness in the acotiamide 100 mg group was significantly higher compared to placebo group. In addition, the post hoc analysis showed that in patients whose main complaints are meal-related symptoms such as postprandial fullness, upper abdominal bloating and/or early satiety, the improvement rate of 'OTE' at final evaluation in acotiamide 100 mg group was significantly superior to that in the placebo group. These results suggest that acotiamide possesses efficacy on FD and more specifically its meal-related symptoms of FD.Keywords
This publication has 21 references indexed in Scilit:
- A dose‐ranging, placebo‐controlled, pilot trial of Acotiamide in patients with functional dyspepsiaNeurogastroenterology & Motility, 2009
- Functional Gastroduodenal DisordersGastroenterology, 2006
- A Study of Candidate Genotypes Associated with Dyspepsia in a U.S. CommunityAmerican Journal of Gastroenterology, 2006
- American Gastroenterological Association Technical Review on the Evaluation of DyspepsiaGastroenterology, 2005
- Dyspepsia and Irritable Bowel Syndrome After a Salmonella Gastroenteritis Outbreak: One-Year Follow-up Cohort StudyGastroenterology, 2005
- G-protein β3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia 1 ☆Gastroenterology, 2004
- Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsiaAmerican Journal of Gastroenterology, 2003
- Symptoms associated with hypersensitivity to gastric distention in functional dyspepsiaGastroenterology, 2001
- Functional gastroduodenal disordersGut, 1999
- Three-Month Prevalence Rates of Gastrointestinal Symptoms and the Influence of Demographic Factors: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)Scandinavian Journal of Gastroenterology, 1999